Laseroptek Co., Ltd.
Financials
Valuation Metrics
Laseroptek Co., Ltd.'s Market Cap is ₩462B. At end of 2025 it was ₩769B. Ranked #1814 of 2,421 in KR market (top 75%), #1110 of 1,640 on KOSDAQ (top 68%), #75 of 96 in Health Care Equipment & Services (top 78%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 46.17B KRW | KR#1,814/2,421 Sec#75/96 |
| Revenue | 31.68B KRW | KR#2,013/2,421 Sec#65/96 |
| Net Income | -6.94B KRW | KR—/2,421 Sec—/96 |
| Total Assets | 46.33B KRW | KR#2,237/2,421 Sec#77/96 |
| Net Assets | 30.06B KRW | KR#2,175/2,421 Sec#78/96 |
| Employees | 79 | KR#1,817/2,421 Sec#71/96 |
| Value | ||
| P/B | 1.54x | KR#1,783/2,421 Sec#59/96 |
| P/S | 1.46x | KR#1,621/2,421 Sec#42/96 |
| FCF Yield | -15.38% | KR—/2,421 Sec—/96 |
| Profitability | ||
| ROE | -23.10% | KR#2,123/2,421 Sec#76/96 |
| ROA | -14.98% | KR#2,189/2,421 Sec#77/96 |
| Op. Margin | -32.86% | KR#2,188/2,421 Sec#74/96 |
| Revenue Growth | 33.82% | KR#342/2,421 Sec#16/96 |
| Financial Health | ||
| Debt Ratio | 54.16% | KR#1,019/2,421 Sec#59/96 |
| Total Debt | 7.83B KRW | KR#1,694/2,421 Sec#54/96 |
| FCF | -7.10B KRW | KR#1,595/2,421 Sec#55/96 |
| Cash | 9.82B KRW | KR#1,706/2,421 Sec#57/96 |
| Current Ratio | 2.64x | KR#648/2,421 Sec#38/96 |
| Performance | ||
| 1Y Return | -55.92% | KR#2,148/2,421 Sec#76/96 |
| 1M Return | 18.25% | KR#273/2,421 Sec#8/96 |
| From 52W High | -59.61% | KR#1,847/2,421 Sec#60/96 |
| 1Y MDD | -68.33% | KR#1,916/2,421 Sec#67/96 |
| Trading | ||
| Volume | 13,548 shares | KR#1,784/2,421 Sec#72/96 |
| Trading Value | 42.6M KRW | KR#1,892/2,421 Sec#75/96 |
| Foreign Own. | 1.84% | KR#1,689/2,421 Sec#62/96 |
| Per Share | ||
| EPS | -468 KRW | KR—/2,421 Sec—/96 |
| BPS | 2,025 KRW | KR#2,061/2,421 Sec#67/96 |
Company Info
LASEROPTEK, established in 2000, specializes in developing and manufacturing medical devices based on laser original technology, and was listed on KOSDAQ in 2024. Initially, it developed laser products for semiconductor and automobile manufacturing processes, but later expanded into skin aesthetics and disease treatment fields following the growth of the beauty device market. The company entered the domestic laser beauty device market in 2005 with LOTUS and HELIOS, achieving overseas expansion in 2009 with US FDA and Europe CE certifications. LASEROPTEK is headquartered in Seongnam-si, Gyeonggi-do.